Submissions from 2021
Post-Mortem Diagnostics in COVID-19 AKI, More Often but Timely, J. L. Rosenstock and V. Bijol
Submissions from 2020
Transplantation of mesenchymal stem cells preserves podocyte homeostasis through modulation of parietal epithelial cell activation in adriamycin-induced mouse kidney injury model., R. Aslam, A. Hussain, K. Cheng, V. Kumar, A. Malhotra, S. Gupta, and P. C. Singhal
An approach to predicting patient experience through machine learning and social network analysis., V. Bari, J. S. Hirsch, J. Narvaez, R. Sardinia, K. R. Bock, M. I. Oppenheim, and M. Meytlis
The Value of Intravenous Iron: Beyond the Cave of Speculation, D. W. Coyne and S. Fishbane
Difelikefalin in Hemodialysis Patients with Pruritus Reply, S. Fishbane
How I treat renal anemia, S. Fishbane and D. W. Coyne
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19., S. Fishbane and J. S. Hirsch
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus, S. Fishbane, A. Jamal, C. Munera, W. Wen, and F. Menzaghi
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients, S. Fishbane, V. Mathur, M. J. Germain, S. Shirazian, S. Bhaduri, C. Munera, R. H. Spencer, and F. Menzaghi
Renal Transplantation after Transcatheter Aortic Valve Replacement: Case Report, K. Gangadharan, R. Parameswaranunni, M. Merzkani, E. Molmenti, and M. Bhaskaran
Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19., P Golmai, CP Larsen, MV DeVita, SJ Wahl, A Weins, HG Rennke, V Bijol, and JL Rosenstock
Acute kidney injury in patients with COVID-19: an update on the pathophysiology., H. Izzedine and K. D. Jhaveri
Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?, H Izzedine, KD Jhaveri, and MA Perazella
COVID-19 therapeutic options for patients with kidney disease, H. Izzedine, K. D. Jhaveri, and M. A. Perazella
Selinexor-associated hyponatremia: single-center, real-world data, J. Kala, O. Mamlouk, and K. D. Jhaveri
Aquapheresis: An Institutional Experience, S. K. Khine, E. Lam, K. Dholakia, S. J. Scheinerman, and M. DeVita
Lung Ultrasound in Hemodialysis Patients: Is it Practical to Scan 28 Zones?, A. Koratala and D. W. Ross
Lorlatinib induced proteinuria: A case report, C. Lee, R. Wanchoo, and N. Seetharamu
Usefulness of Elevated Troponin to Predict Death in Patients with COVID-19 and Myocardial Injury., D. T. Majure, L. Gruberg, S. G. Saba, C. Kvasnovsky, J. S. Hirsch, R. Jauhar, and Northwell Health COVID-19 Research Consortium
Occupational kidney stones, D. A. Malieckal and D. S. Goldfarb
Treatment of parvovirus B19 viremia to facilitate kidney transplantation in a patient with collapsing glomerulopathy., V. Nair, N. Jandovitz, K. D. Jhaveri, D. Hirschwerk, E. Grodstein, V. Bijol, E. Molmenti, and L. Teperman
Time-dependent effect, immortal bias, and competing risk: 3 components that should be handled to assess the impact of covariates on occurrence of acute kidney injury Reply, J. H. Ng, J. S. Hirsch, K. D. Jhaveri, and S. Fishbane
Clinical Management of Hyperkalemia, B. F. Palmer, J. J. Carrero, D. J. Clegg, G. B. Colbert, M. Emmett, S. Fishbane, D. J. Hain, E. Lerma, M. Onuigbo, M. R. Weir, and +3 additional authors
Use of Semiprivate Smartphone Communication Applications in Nephrology Education, A. Pandya, M. E. Elrggal, and K. D. Jhaveri
Panconsultitis, an Epidemic, R. Parikh, C. Halinski, K. D. Jhaveri, and G. Neck
Aggressive versus conservative fluid resuscitation in septic hemodialysis patients, K. Rajdev, L. Leifer, G. Sandhu, B. Mann, S. Pervaiz, S. Lahan, A. H. Siddiqui, S. Habib, B. Joseph, and S. El-Sayegh
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study., S. D. Roger, P. T. Lavin, E. V. Lerma, P. A. McCullough, J. Butler, B. S. Spinowitz, S. von Haehling, M. Kosiborod, S. Fishbane, D. K. Packham, and +1 additional author
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials, S. Roger, B. Spinowitz, E. Lerma, S. Fishbane, S. Ash, J. Martins, C. M. Quinn, and D. Packham
Onconephrology: The intersections between the kidney and cancer, M. H. Rosner, K. D. Jhaveri, B. A. McMahon, and M. A. Perazella
Phospholipase A2 Receptor Antibody–Positive Pregnancy: A Case Report, M. Sachdeva, L. H. Beck, I. Miller, V. Bijol, and S. Fishbane
Home Dialysis in the Time of COVID-19: Reflections on Rapidly Changing Policies., M. Sachdeva, K. D. Jhaveri, and S. Fishbane
Opportunities for Subspecialization in Nephrology, M. Sachdeva, A. D. Shah, H. K. Singh, D. A. Malieckal, J. Rangaswami, and K. D. Jhaveri
Roxadustat for Anemia in Patients with Chronic Kidney Disease, H. H. Shah and S. Fishbane
Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection, H. H. Shah, N. N. Uppal, and S. Fishbane
How to determine kidney function in cancer patients?, B. Sprangers, A. Abudayyeh, S. Latcha, M. A. Perazella, and K. D. Jhaveri
Improving Cancer Care for Patients With Chronic Kidney Disease, B. Sprangers, K. D. Jhaveri, and M. A. Perazella
Acute kidney injury after ruxolitinib: Common complication, uncommon cause, S. Strohbehn, H. Seethapathy, N. Rusibamayila, I. Strohbehn, M. Lee, G. Hobbs, A. Keyzner, K. D. Jhaveri, and M. E. Sise
Hyponatremia in a Patient With Cancer, N. N. Uppal, R. Wanchoo, R. Barnett, A. Sinha, and K. D. Jhaveri
Rituximab in fibrillary glomerulonephritis: fumble or forward progress?, S. Wadhwani and K. D. Jhaveri
Response to Thrombotic Microangiopathy: COVID-19 or Hydroxychloroquine?, R. Wanchoo, M. L. Barilla-LaBarca, and K. D. Jhaveri
Hyponatremia in the cancer patient., B. T. Workeneh, K. D. Jhaveri, and H. Rondon-Berrios
Submissions from 2019
Renal pathology practice globally: identifying needs and meeting the challenge, V. Bijol, Y. M. Farag, D. C. Harris, A. Levin, P. Roy-Chaudhury, A. K. Singh, and K. D. Jhaveri
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia, S. Fishbane, M. Ford, M. Fukagawa, K. McCafferty, A. Rastogi, B. Spinowitz, K. Staroselskiy, K. Vishnevskiy, V. Lisovskaja, S. Bhandari, and +2 additional authors
Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?, S. Fishbane, D. W. Ross, and S. Hong
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease, S. Fishbane, B. S. Spinowitz, W. A. Wisemandle, and N. E. Martin
Adverse Events Associated With Immune Checkpoint Inhibitors, K. D. Jhaveri and R. Wanchoo
APOL1 and kidney cell function, V. Kumar and P. C. Singhal
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial., F. Locatelli, T. Hannedouche, S. Fishbane, Z. Morgan, D. Oguey, and W. B. White
Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria, D. A. Malieckal, F. Modersitzki, K. Mara, F. T. Enders, J. R. Asplin, and D. S. Goldfarb
Ibrutinib induced acute tubular injury: A case series and review of the literature, S. Manohar, A. Bansal, R. Wanchoo, V. Sakhiya, S. Lucia, and K. D. Jhaveri
Retooling nephrology with ultrasound, W. C. O’Neill and D. W. Ross
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease, P. E. Pergola, S. Fishbane, and T. Ganz
Fibrillary Glomerulonephritis: An Update, J. L. Rosenstock and G. S. Markowitz
Is There a Role for Desensitization in Intestinal Transplantation?, A. D. Santeusanio, J. Moon, V. Nair, and K. R. Iyer
Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease, H. H. Shah and S. Fishbane
Increasing Medical Student Interest in Nephrology, S. M. Sozio, K. A. Pivert, H. H. Shah, H. A. Chakkera, A. R. Asmar, M. R. Varma, B. D. Morrow, A. B. Patel, K. Leight, and M. G. Parker
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study, B. S. Spinowitz, S. Fishbane, P. E. Pergola, S. D. Roger, E. V. Lerma, J. Butler, S. von Haehling, S. H. Adler, J. Zhao, D. K. Packham, and +4 additional authors
Cancer Survivorship, B. Sprangers, K. D. Jhaveri, and M. A. Perazella
Acute kidney injury in hematopoietic stem cell transplantation, R. Wanchoo, B. R. Stotter, R. L. Bayer, and K. D. Jhaveri
Monoclonal gammopathy-associated thrombotic microangiopathy, J. C. Yui, D. Garceau, K. D. Jhaveri, R. Wanchoo, V. Bijol, I. Glezerman, H. Hassoun, A. Dispenzieri, S. J. Russell, and N. Leung
Submissions from 2018
Kidney transplant wait list: Review and current trends, L. M. Clayton, D. Rizzolo, and V. Nair
The Social Media Revolution in Nephrology Education, G. B. Colbert, J. Topf, K. D. Jhaveri, T. Oates, M. N. Rheault, S. Shah, S. Hiremath, and M. A. Sparks
Opening an onconephrology clinic: recommendations and basic requirements, L. Cosmai, C. Porta, M. A. Perazella, V. Launay-Vacher, M. H. Rosner, K. D. Jhaveri, M. Floris, A. Pani, C. Teuma, M. Gallieni, and +1 additional author
Opportunities for increasing the rate of preemptive kidney transplantation, S. Fishbane and V. Nair
Intravenous epoetin Alfa-epbx versus epoetin alfa for treatment of anemia in end-stage kidney disease, S. Fishbane, B. Singh, S. Kumbhat, W. A. Wisemandle, and N. E. Martin
Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018, S. Fishbane and B. Spinowitz
Planning and evaluation for vascular access in the elderly, C. Halinski and H. M. Koncicki
Medication discrepancies in late-stage chronic kidney disease., J. Ibrahim, A. D. Hazzan, A. T. Mathew, V. Sakhiya, M. Zhang, C. Halinski, and S. Fishbane
Adverse Events Associated with Immune Checkpoint Blockade, K. D. Jhaveri and M. A. Perazella
Chimeric Antigen Receptor T Cell Therapy and the Kidney What the Nephrologist Needs to Know, K. D. Jhaveri and M. H. Rosner
Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists, M. C. Mallappallil, S. Fishbane, R. Wanchoo, E. Lerma, A. Roche-Recinos, and M. Salifu
Introduction to unresolved issues in the care of dialysis patients, A. T. Mathew and S. Fishbane
Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure, P. A. McCullough, K. Uhlig, J. F. Neylan, P. E. Pergola, and S. Fishbane
Strongyloides stercoralis−Associated Tip Variant Focal Segmental Glomerulosclerosis, M. Merzkani, N. N. Uppal, D. W. Ross, P. Gautam-Goyal, P. Malhotra, H. H. Shah, K. D. Jhaveri, and V. D. D'Agati
Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia, P. E. Pergola, S. Fishbane, R. D. LeWinter, J. F. Neylan, K. Uhlig, G. A. Block, and G. M. Chertow
Lung ultrasonography in end-stage renal disease: Moving from evidence to practice-a narrative review, D. W. Ross, M. M. Abbasi, K. D. Jhaveri, M. Sachdeva, I. Miller, R. Barnett, M. Narasimhan, P. Mayo, M. Merzkani, and A. T. Mathew
Lung Ultrasonography in the Acutely Dyspneic Hemodialysis Patient., D. W. Ross and K. D. Jhaveri
Left Ventricular Assist Devices and the Kidney, D. W. Ross, G R. Stevens, R. Wanchoo, D. T. Majure, S. Jauhar, H. A. Fernandez, M. Merzkani, and K. D. Jhaveri
Should obesity affect suitability for kidney donation?, M. Sachdeva
Is there an established hemoglobin target range for patients undergoing chronic dialysis?, H. H. Shah and S. Fishbane
Risk factors associated with post-kidney transplant malignancies: An article from the Cancer-Kidney International Network, B. Sprangers, V. Nair, V. Launay-Vacher, L. V. Riella, and K. D. Jhaveri
Aging phenotype(s) in kidneys of diabetic mice are p66ShcA dependent., H. Vashistha, L. Marrero, K. Reiss, A. Cohen, A. Malhotra, T. Javed, A. E. Bradley, F. Abbruscato, P. C. Singhal, L. G. Meggs, and +8 additional authors
Emerging Concepts in Hematopoietic Stem Cell Transplantation–Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments, R. Wanchoo, R. L. Bayer, C. Bassil, and K. D. Jhaveri
Submissions from 2016
Quality Measurement in Wonderland: The Curious Case of a Dialysis Readmissions Measure, S. Fishbane and J. B. Wish
Nephrologists as Educators: Clarifying Roles, Seizing Opportunities, K. D. Jhaveri and M. A. Perazella
Angiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: roleof c-Abl, Q. Yang, Y. Ma, Y. Liu, W. Liang, X. Chen, Z. Ren, H. Wang, P. C. Singhal, and G. Ding
Submissions from 2015
Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes, M. Alfano, P. Cinque, G. Giusti, S. Proietti, M. Nebuloni, S. Danese, S. D'Alessio, M. Genua, P. C. Singhal, J. Mikulak, and +5 additional authors
On the safety of intravenous iron, evidence trumps conjecture, M. Auerbach, J. Adamson, A. Bircher, C. Breymann, S. Fishbane, A. Gafter-Gvili, C. Gasche, J. Gilreath, G. Grazzini, A. Shander, and +7 additional authors
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia, D. M. Charytan, S. Fishbane, J. Malyszko, P. A. McCullough, and D. Goldsmith
Challenges and opportunities in late-stage chronic kidney disease, S. Fishbane, A. D. Hazzan, C. Halinski, and A. T. Mathew
Ferric pyrophosphate citrate (Triferic) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients, S. N. Fishbane, A. K. Singh, S. H. Cournoyer, K. K. Jindal, P. Fanti, C. D. Guss, V. H. Lin, R. D. Pratt, and A. Gupta
The Emerging Role of Biosimilar Epoetins in Nephrology in the United States, S. Fishbane and H. H. Shah
Integrating Real Time Data to Improve Outcomes in Acute Kidney Injury, J. S. Hirsch and S. Mohan
HARVEST, a longitudinal patient record summarizer, J. S. Hirsch, J. S. Tanenbaum, S. Lipsky Gorman, C. Liu, E. Schmitz, D. Hashorva, A. Ervits, D. Vawdrey, M. Sturm, and N. Elhadad
Carfilzomib-induced nephrotoxcity, K. D. Jhaveri and R. Wanchoo
The Need for Enhanced Training in Nephrology Medical Education Research, K. D. Jhaveri, R. Wanchoo, L. Maursetter, and H. H. Shah
Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1, A. K. Khatua, A. M. Cheatham, E. D. Kruzel, P. C. Singhal, K. Skorecki, and W. Popik
An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms, H. M. Koncicki, F. Brennan, K. Vinen, and S. N. Davison
Communication Skills and Decision Making for Elderly Patients With Advanced Kidney Disease: A Guide for Nephrologists, H. M. Koncicki and J. O. Schell
Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN), X. Lan, T. K. Rao, P. N. Chander, K. Skorecki, and P. C. Singhal